Acceptability Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene

Sanofi

Status and phase: Completed; Phase 3

Conditions: Hygiene

Treatments: Drug: lactoserum

Study type: Interventional

Funder types: Industry

Identifiers

NCT00370162

LACTO_L_01839

Details and patient eligibility

About

The purpose of this study is to demonstrate the safety of the gynaecological formulation in normal and usual usage condition.

Sex: Female

Ages: 18 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Integral skin in the tested region

Exclusion criteria

• Pregnancy or breastfeeding women
• Use of antiinflammatory or immunosuppression drugs
• Topical medication use at the tested region
• Active cutaneous gynaecological disease
• Personal history of allergic disease at the area to be treated
• Allergic or atopic history

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)